A Preliminary Controlled Trial of Cognitive Behavioral Therapy in Clozapine-Resistant Schizophrenia

dc.creatorBARRETTO, Eliza Martha de Paiva
dc.creatorKAYO, Monica
dc.creatorAVRICHIR, Belquiz S.
dc.creatorSA, Antonio Reis
dc.creatorCAMARGO, Maria das Gracas Miquelutti
dc.creatorNAPOLITANO, Isabel Cristina
dc.creatorNERY, Fabiano Goncalves
dc.creatorPINTO JR., Jony Arrais
dc.creatorBANNWART, Silvia
dc.creatorSCEMES, Silvia
dc.creatorSARNO, Elaine Di
dc.creatorELKIS, Helio
dc.date.accessioned2012-10-19T17:00:00Z
dc.date.accessioned2018-07-04T15:03:27Z
dc.date.available2012-10-19T17:00:00Z
dc.date.available2018-07-04T15:03:27Z
dc.date.created2012-10-19T17:00:00Z
dc.date.issued2009
dc.identifierJOURNAL OF NERVOUS AND MENTAL DISEASE, v.197, n.11, p.865-868, 2009
dc.identifier0022-3018
dc.identifierhttp://producao.usp.br/handle/BDPI/21213
dc.identifier10.1097/NMD.0b013e3181be7422
dc.identifierhttp://dx.doi.org/10.1097/NMD.0b013e3181be7422
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1617988
dc.description.abstractThe use of cognitive-behavior therapy (CBT) in addition to antipsychotic regimen to treat persistent psychotic symptoms of schizophrenia is growing. The aim of this study was to compare the efficacy of CBT to a befriending (BF) control group in patients with schizophrenia who are refractory to clozapine. Twenty-one patients completed the 21-week trial. In comparison with the control group, the CBT group showed a significant improvement in the General Psychopathology and total score of the Positive and Negative Syndrome Scale, as well as an improvement Of Quality of Life scale. The improvement in psychopathology persisted at 6-month follow-up assessment.
dc.languageeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relationJournal of Nervous and Mental Disease
dc.rightsCopyright LIPPINCOTT WILLIAMS & WILKINS
dc.rightsrestrictedAccess
dc.subjectCognitive-behavior therapy
dc.subjectschizophrenia
dc.subjecttreatment-resistant
dc.titleA Preliminary Controlled Trial of Cognitive Behavioral Therapy in Clozapine-Resistant Schizophrenia
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución